Beyond the Chemical List: Building Regulatory Readiness Into Product Data

Recognizing an emerging chemical regulatory signal is useful only if a company can determine what that signal means for its products, facilities, suppliers, workers, and markets. As regulators move toward earlier and more data-intensive chemical oversight, another transformation is occurring further down the value chain: product information itself is becoming more structured, portable, and potentially useful for anticipating regulatory change.

Digital product passports offer one visible example, but the larger compliance challenge extends well beyond any single EU initiative. Companies increasingly need to connect chemical identity and hazard information with product composition, suppliers, concentrations, uses, facilities, exposure, and markets and retrieve that information before a new regulatory requirement makes the question urgent.

The result is a different kind of regulatory readiness. Knowing that a chemical is attracting scrutiny is the first step. Knowing exactly where that chemical sits within your company’s products and operations, what function it performs, who might be exposed, and what would have to change if regulatory requirements shift is another matter entirely.

Upstream Info for Products, Too

The upstream-information trend is moving beyond traditional chemical registration and into the value chain for products. The EU’s Digital Product Passport (DPP), for example, creates infrastructure through which standardized product information can travel through value chains. The European Commission’s Digital Product Passport portal describes the DPP as a mechanism for storing and sharing information about products and their sustainability, circularity, and compliance.

The DPP Registry went live on July 20, 2026, providing the infrastructure for product passports required under the Ecodesign for Sustainable Products Regulation and other applicable EU legislation.

Batteries provide an early example of mandatory product passports. Under the EU Batteries Regulation, battery passports will make specified product-level information digitally accessible for covered batteries, while the broader regulation contains requirements addressing hazardous substances, carbon footprints, recycled content, raw materials, and supply-chain due diligence.

For companies, one potential benefit is having information available before a regulatory change forces them to go back through the supply chain looking for it, according to Josh Maunder, 3E Solutions Advisor Team lead.

“Digital product passports could significantly reduce the amount of reactive supplier outreach required when regulations change,” Maunder said. “If more standardized material and component information is pushed through the supply chain with the product, companies would be less dependent on repeatedly contacting individual suppliers to obtain information.”

That information also could give regulatory and product stewardship teams more time to respond to emerging requirements. Maunder said companies could compare product information against proposed or draft regulations to assess potential impacts before requirements are finalized, allowing them to begin considering testing, reformulation, sourcing changes, or recertification.

“The real benefit is the ability to identify an impact and start preparing for it before the regulation is published, rather than beginning the process once the compliance deadline is already approaching,” Maunder said.

The implication is significant: The information regulators once might have obtained through individual reporting requirements or inspections increasingly can become standardized information that travels with a product.

Next Compliance Challenge Is Regulatory Readiness

The shift has an important implication for chemical manufacturers, importers, distributors, and downstream users. Companies cannot necessarily wait until a substance is proposed for restriction to begin asking where it is used. This is particularly true given increasing emphasis on emerging hazards that are not part of the existing regulatory targets, said Dr. Neil Hunt, principal at Yordas Group by 3E.

“The recent inclusion of endocrine disruptors and substances that are persistent, mobile, and toxic (PMT) in the EU CLP (Classification, Labeling, and Packing) Regulation is an example of this, where registrants are doing retrospective hazard assessments of their registered substances to assess them against these emerging hazard criteria,” said Hunt. “The fact that most other global regions have not yet adopted these classifications outlines the emerging characteristics of these areas of toxicology. Other health impacts not yet directly addressed by hazard classification have been linked to exposure to the chemicals, such as obesity and degenerative brain diseases.”

Academic research can sometimes overstate the potential risks associated with emerging hazards, particularly when findings from in vitro studies are extrapolated to whole-organism effects without sufficient scientific evidence, added Hunt. As a result, intensive monitoring of such literature may be premature until the results of ongoing research into bridging the gap between individual biological reaction and whole organism effects can be confidently integrated into regulatory decision-making. In the meantime, however, companies may want to consider emerging hazards as part of their innovation and product-development strategies.

“Regulators are increasingly recognizing the importance of regulatory preparedness to ensure existing regulations are fit-for-purpose for emerging technologies,” Hunt pointed out. “This will need improved dialogue between industry, innovators, and regulators through mechanisms such as regulatory sandboxes. Companies that engage with these initiatives will get a first-hand view of the direction that decision-makers might take in the upcoming decade.”

Regulatory readiness therefore involves more than tracking what governments publish. It also means determining whether the organization possesses enough internal information to understand what a new hazard classification, information request, proposed restriction, or emerging scientific concern could mean for its portfolio.

Can Companies Answer the Same Questions Regulators Are Asking?

Product stewardship and EHS teams increasingly need to be able to answer questions such as: Which products contain the substance? At what concentrations? What function does it perform? How much moves through each jurisdiction? Which facilities manufacture or use it? Which workers could be exposed? What monitoring information exists? Where might environmental releases occur? Which downstream applications exist? What information resides with suppliers or customers rather than within the company?

Those questions can become particularly important when governments begin seeking information before deciding whether additional regulation is necessary.

Canada’s recent Section 71 exercise provides one example. The information requests do not themselves restrict the 200 substances covered. Instead, the government is seeking information about how those substances are used in Canadian commerce to support prioritization, risk assessment, and potential risk-management decisions.

For a company trying to anticipate the potential effect of such a development, simply knowing whether it uses one of the substances may not be sufficient. Understanding quantities, concentrations, products, facilities, uses, releases, suppliers, and customers can be necessary to determine the organization’s actual exposure to a future regulatory change.

That makes the ability to connect regulatory intelligence with internal chemical and product information increasingly important. A horizon-scanning team might identify a signal months or years before a requirement takes effect, but the value of that warning diminishes if the organization cannot determine where the affected chemical is used.

Collecting the Data Isn’t Enough

But collecting that information is only part of the challenge, according to 3E's Maunder.

“The challenge is not simply obtaining more data. Companies must determine who owns each data element, who is responsible for validating and updating it, where it is stored, and which system is the authoritative source,” Maunder said. “Increased supply chain transparency will make inaccurate estimates, incomplete records, and inconsistent classifications much more visible.”

That creates a governance problem as much as a data problem. Information about a single substance can reside in regulatory systems, product-composition records, supplier declarations, safety data sheets, procurement systems, facility records, industrial hygiene programs, and other databases. The information may have been collected at different times and for different purposes.

The companies best prepared for the next generation of chemical regulation, therefore, may not simply be those with the best restricted-substance lists. They may be the companies that can connect regulatory intelligence with substance, product, supplier, facility, use, and exposure information quickly enough to understand a regulatory signal before it becomes a compliance deadline.

As Maunder explained, that requires more than collecting life cycle information. “Companies must be able to demonstrate that the information and claims associated with a product are accurate, traceable, current, and actively managed throughout its life cycle.”

New government information requirements themselves can provide an early warning.

“New information requirements can provide an early indication that a material or chemical is attracting greater regulatory scrutiny, although they should not automatically be interpreted as evidence that a restriction will follow,” Maunder said.

That qualification matters. Regulatory readiness does not require companies to treat every information request, scientific study, or proposed classification as an inevitable restriction. It requires the ability to investigate the signal and determine what it could mean for the business.

From Regulatory Intelligence to Product Intelligence

Restricted-substance lists will remain fundamental to chemical compliance. Companies still must know which chemicals are prohibited, restricted, reportable, authorized, or subject to particular thresholds in the markets where they operate.

“Monitoring published restricted-substance lists is still key to ensure and demonstrate basic compliance,” asserted Tan Sun, a senior regulatory consultant with Yordas Group by 3E. “For the vast majority of companies, daily product stewardship, formulation decisions, and global market access strategies are strictly dictated by these existing lists and their specific legal thresholds.”

The emerging challenge is therefore not to replace list-based compliance but to connect it with another layer of intelligence.

Digital product passports illustrate what more standardized and portable product information could make possible. Emerging hazard criteria demonstrate why companies may need information before a substance becomes a familiar regulatory target. Government information requests show how quickly questions about quantities, uses, facilities, exposures, and supply chains can become relevant.

Regulatory readiness ultimately depends on connecting two kinds of intelligence that companies often manage separately: intelligence about what regulators are beginning to examine and intelligence about where those substances, hazards, and exposures exist within the company’s own portfolio.

The advantage of better product and chemical intelligence is that companies do not have to wait for a substance to appear on a restricted-substance list before asking the questions that may eventually determine compliance: Where is it? Why is it there? Who is exposed? What alternatives exist? And how quickly can the company act if today’s regulatory signal becomes tomorrow’s requirement?

That may ultimately be the difference between reacting to a new chemical restriction and seeing it coming.

(This is Part 3 of a three-part series. Part 1 is Horizon Scanning: Moving From Restricted Lists to Regulatory Intelligence, which examines the move from restricted-substance lists toward regulatory intelligence. Part 2, Before the Restriction: Reading Chemical Regulatory Signals, focuses on the signals that can indicate emerging chemical scrutiny.)